Ignite Creation Date:
2024-05-06 @ 4:00 PM
Last Modification Date:
2024-10-26 @ 2:01 PM
Study NCT ID:
NCT04836715
Status:
COMPLETED
Last Update Posted:
2024-06-12
First Post:
2021-04-05
Brief Title:
Prevalence of Visual Dysfunction in Neurological Disorders
Sponsor:
University of Florida
Organization:
University of Florida
Study Overview
Official Title:
Prevalence of Visual Dysfunction in Persons With Parkinsons Disease and Other Neurological Disorders
Status:
COMPLETED
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The objective is to determine the prevalence of visual dysfunction in People with Parkinsons Disease PwP The investigators will administer the Visual Impairment in Parkinsons Disease Screen and Revised-Self-Report Assessment of Functional Visual Performance Patients seen at Fixel Institute and their caregivers will be invited to participate Responses to the 2 questionnaires will help determine prevalence rates of visual dysfunction in PwP compared to those both with and without other neurological conditions
Detailed Description:
The purpose of this study is to identify the prevalence of visual dysfunction among Persons with Parkinsons Disease compared to other neurological conditions and controls without neurological conditions
Data will be collected anonymously via RedCap Patients seen at the Fixel Institute that have consented to be contacted regarding research opportunities will be recruited via blast email and advertisement in our Institutes monthly newsletter the Movement Messenger The email and newsletter will contain a link for participation in surveys within RedCap so the surveys can be completed anonymously at home Participation will be completely voluntary and responses will be recorded anonymously Data will include responses to the following screening questions the VIPDQ Visual Impairment in PD Questionnaire and the R-SRAFVP Revised-Self-Report Assessment of Functional Visual Performance
The investigators will calculate the prevalence of visual impairment from the VIPDQ and dysfunction in performance of daily activities from the R-SRAFVP for PwP and compare this to the prevalence occurring in other neurological populations as well as the population without any neurological conditions Other data are collected so the investigators can then evaluate potential confounds or covariates To ensure statistical methods are accurate a statistician will be consulted
Data will be collected anonymously via RedCap Patients seen at the Fixel Institute that have consented to be contacted regarding research opportunities will be recruited via blast email and advertisement in our Institutes monthly newsletter the Movement Messenger The email and newsletter will contain a link for participation in surveys within RedCap so the surveys can be completed anonymously at home Participation will be completely voluntary and responses will be recorded anonymously Data will include responses to the following screening questions the VIPDQ Visual Impairment in PD Questionnaire and the R-SRAFVP Revised-Self-Report Assessment of Functional Visual Performance
The investigators will calculate the prevalence of visual impairment from the VIPDQ and dysfunction in performance of daily activities from the R-SRAFVP for PwP and compare this to the prevalence occurring in other neurological populations as well as the population without any neurological conditions Other data are collected so the investigators can then evaluate potential confounds or covariates To ensure statistical methods are accurate a statistician will be consulted
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None